{
    "accession": "ENCBS518DQO",
    "age": "50",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "NTR:0000497",
    "biosample_term_name": "activated naive CD4-positive, alpha-beta T cell",
    "biosample_type": "primary cell",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/b2a06b24-7b61-4c86-b556-1813f8b67484/@@download/attachment/Isolation%20and%20activation%20or%20stimulation%20of%20Immune%20cells%20rev%2009292022-2%20.pdf",
            "document_type": "cell isolation protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO641WTL",
    "lab": "John Stamatoyannopoulos, UW",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "StemExpress",
    "summary": "Homo sapiens male adult (50 years) activated naive CD4-positive, alpha-beta T primary cell treated with 50 U/mL Interleukin-2 for 72 hours, anti-CD3 and anti-CD28 coated beads for 72 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 72,
            "duration_units": "hour",
            "treatment_term_id": "UniProtKB:P60568",
            "treatment_term_name": "Interleukin-2",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "duration": 72,
            "duration_units": "hour",
            "treatment_term_name": "anti-CD3 and anti-CD28 coated beads",
            "treatment_type": "antibody"
        }
    ]
}